Belite Bio ADR Corporate Bonds and Leverage Analysis

BLTE Stock  USD 64.70  1.00  1.52%   
The current year's Net Debt To EBITDA is expected to grow to 2.91, whereas Short and Long Term Debt Total is forecasted to decline to about 841.7 K. . Belite Bio's financial risk is the risk to Belite Bio stockholders that is caused by an increase in debt.
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.004025
Current Value
0.003578
Quarterly Volatility
0.00025068
 
Credit Downgrade
 
Yuan Drop
 
Covid
The current year's Change To Liabilities is expected to grow to about 54.3 K, whereas Total Current Liabilities is forecasted to decline to about 2.3 M.
  
Check out the analysis of Belite Bio Fundamentals Over Time.
View Bond Profile
Given the importance of Belite Bio's capital structure, the first step in the capital decision process is for the management of Belite Bio to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Belite Bio ADR to issue bonds at a reasonable cost.

Belite Bio ADR Debt to Cash Allocation

Many companies such as Belite Bio, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Belite Bio ADR currently holds 886 K in liabilities. Belite Bio ADR has a current ratio of 34.31, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Belite Bio's use of debt, we should always consider it together with its cash and equity.

Belite Bio Total Assets Over Time

Belite Bio Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Belite Bio uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Belite Bio Debt Ratio

    
  0.36   
It looks as if most of the Belite Bio's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Belite Bio's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Belite Bio, which in turn will lower the firm's financial flexibility.

Belite Bio Corporate Bonds Issued

Most Belite bonds can be classified according to their maturity, which is the date when Belite Bio ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Belite Short Long Term Debt Total

Short Long Term Debt Total

841,700

At present, Belite Bio's Short and Long Term Debt Total is projected to decrease significantly based on the last few years of reporting.

Understaning Belite Bio Use of Financial Leverage

Belite Bio's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Belite Bio's total debt position, including all outstanding debt obligations, and compares it with Belite Bio's equity. Financial leverage can amplify the potential profits to Belite Bio's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Belite Bio is unable to cover its debt costs.
Last ReportedProjected for Next Year
Short and Long Term Debt Total886 K841.7 K
Net Debt-87.3 M-82.9 M
Short Term Debt308 K281.6 K
Net Debt To EBITDA 2.77  2.91 
Cash Flow To Debt Ratio(52.08)(54.69)
Please read more on our technical analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Belite Bio ADR is a strong investment it is important to analyze Belite Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Belite Bio's future performance. For an informed investment choice regarding Belite Stock, refer to the following important reports:
Check out the analysis of Belite Bio Fundamentals Over Time.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.10)
Return On Assets
(0.26)
Return On Equity
(0.40)
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.